Discover the key differences, their roles in diabetes care, and how combining CGM and A1C methods can enhance diabetes management and improve health outcomes.

Discover Orange Biomed’s key takeaways from MEDICA 2024, including innovations in diabetes care, the OBM rapid A1c device, and future healthcare collaborations.

Learn about World Diabetes Day 2024 with the theme “Breaking Barriers, Bridging Gaps”, and innovations like OBM rapid A1c transforming diabetes care, during Diabetes Awareness Month.

Discover Orange Biomed’s journey and innovations in diabetes technology after the Diabetes Technology Meeting 2024, focusing on health equity and solutions.

Explore innovations in A1C testing at the Diabetes Technology Meeting 2024. Learn about Orange Biomed’s OBM rapid A1c and its impact on equitable diabetes care.

Stay Informed Ahead of the Next Diabetes Conference in 2025. The ADA’s (American Diabetes Association) 84th Scientific Sessions, held from… June 21–24 in Orlando, Florida, showcased breakthrough research and discussions

Learn How The Microfluidic Technology In OBM rapid A1c, A New At-Home Device For Monitoring HbA1C, Can Generate Lab-Accurate Results From A Single Drop of Blood For More Accessible And…

5 Women Making Strides in Diabetes Care and Advocacy in 2023. Women’s History Month may be over, but that…

Seattle, WA, October 30, 2023—Orange Biomed—a healthcare startup with cutting-edge diabetes management technology—announced their attendance at major industry events: Diabetes Technology Meeting and MEDICA. Orange Biomed is a medical device